Moderna raises its revenue outlook — but all eyes are on what happens next with its experimental cancer vaccine
· marketwatch.com · popularity 32/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at marketwatch.com →
Summary
The company lifted its revenue outlook for the year, saying it expects revenue to grow as much as 25% in 2026.
Found in: MarketWatch. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 6.